Nitrones have a well-recognized capacity as spin-traps and are considered powerful free radical scavengers, which are two important issues in...
Array
(
[id_prestablog_news] => 1257
[id_shop] => 1
[date] => 2020-03-31 00:00:00
[date_modification] => 2024-02-09 14:15:12
[langues] => ["1","2"]
[actif] => 1
[slide] => 0
[url_redirect] =>
[average_rating] =>
[number_rating] =>
[author_id] => 1
[featured] => 0
[prim_key] => 2472
[id_lang] => 2
[title] => Characterization of a CholesteroNitrone -ISQ-201-- a Novel Drug Candidate for th
[paragraph] => Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic Stroke
[content] => Authors
E Mart’nez-Alonso, A Escobar-Peso, MI Ayuso et al
Lab
Department of Research, IRYCIS, Hospital Ram—n y Cajal, Madrid, Spain
Journal
Antioxidants
Abstract
Nitrones have a well-recognized capacity as spin-traps and are considered powerful free radical scavengers, which are two important issues in hypoxia-induced oxidative stress and cell death in brain ischemia. Consequently, nitrones have been proposed as therapeutic agents in acute ischemic stroke (AIS). In this paper, we update the biological and pharmacological characterization of ISQ-201, a previously identified cholesteronitrone hybrid with antioxidant and neuroprotective activity. This study characterizes ISQ-201 as a neuroprotective agent against the hypoxia-induced ischemic injury. Transitory four-vessel occlusion and middle cerebral artery occlusion (tMCAO) were used to induce cerebral ischemia. Functional outcomes were determined using neurofunctional tests. Infarct area, neuronal death, and apoptosis induction were evaluated. In addition, ISQ-201 reactivity towards free radicals was studied in a theoretical model. ISQ-201 significantly decreased the ischemia-induced neuronal death and apoptosis, in a dose-dependent manner, showing its therapeutic effect when administered up until 6 h after post-ischemic reperfusion onset, effects that remained after 3 months from the ischemic episode. Furthermore, ISQ-201 significantly reduced infarct volume, leading to recovery of the motor function in the tMCAO model. Finally, the theoretical study confirmed the reactivity of ISQ-201 towards hydroxyl radicals. The results reported here prompted us to suggest ISQ-201 as a promising candidate for the treatment of AIS.
BIOSEB Instruments Used
Grip strength test (BIO-GS3)
[meta_description] =>
[meta_keywords] => http://scholar.google.fr/scholar_url?url=https://www.mdpi.com/2076-3921/9/4/291/pdf&hl=fr&sa=X&d=74245280284299071&scisig=AAGBfm2EaJV_ehIJ8jC5DvZQfskd8bF_DA&nossl=1&oi=scholaralrt&hist=dLa5yvYAAAAJ:2499066874814899551:AAGBfm05gyG2UrcKAn4A3z5Ug-ZKBR4IDw
[meta_title] =>
[link_rewrite] => characterization-of-a-cholesteronitrone--isq-201---a-novel-drug-candidate-for-the-treatment-of-ischemic-stroke
[actif_langue] => 1
[read] => 1059
[count_comments] => 0
[id] => 1257
[categories] => Array
(
[40] => Array
(
[id_prestablog_categorie] => 40
[title] => Accidents ischémiques transitoires (AIT)
[link_rewrite] => Accidents-ischemiques-transitoires-AIT
)
[2] => Array
(
[id_prestablog_categorie] => 2
[title] => Publications
[link_rewrite] => publications
)
[11] => Array
(
[id_prestablog_categorie] => 11
[title] => Système Nerveux Central (SNC)
[link_rewrite] => Systeme-Nerveux-Central-SNC
)
)
[authors] =>
[paragraph_crop] => Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of [...]
[link_for_unique] => 1
[products_liaison] => Array
(
[48] => Array
(
[name] => Test d'agrippement
[description_short] => Une méthode simple pour quantifier objectivement la force musculaire des rats et souris et l'effet de drogues, toxines, maladies musculaires (ex: myopathie) et neurodégénératives. Cette mesure de force est souvent employée en association avec le test de coordination motrice ROTAROD: un sujet présentant une coordination normale montrera des résultats médiocres en cas de faible force musculaire. Un must pour vos recherches sur l'activité, la coordination et le contrôle musculaire: particulièrement utile pour vos études sur les maladies de Parkinson et Huntington.
Nouveautés GS4 - 2023: Écran couleur rétroéclairé (meilleure lisibilité), pédale de remise à zéro, durée de batterie optimisée, taille de mémoire augmentée à 500 valeurs, compteur d'animaux, port USB (transfert de données/charge)


[thumb] =>
[img_empty] => /var/www/vhosts/de3310.ispfr.net/preprod.bioseb.com/modules/prestablog/views/img/product_link_white.jpg
[image_presente] => 1
[link] => https://preprod.bioseb.com/fr/activite-systeme-moteur-coordination/48-grip-strength-test.html
)
)
)
1 En lire plus